Ken Griffin Surmodics Inc Put Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$25.39 - $42.1 $33,007 - $54,730	-1,300 Reduced 27.66%	3,400 $142,000
Q1 2024 May 15, 2024	BUY	$27.44 - $35.56 $30,184 - $39,116	1,100 Added 30.56%	4,700 $137,000
Q4 2023 Feb 14, 2024	SELL	$28.47 - $38.49 $2,847 - $3,849	-100 Reduced 2.7%	3,600 $130,000
Q3 2023 Nov 14, 2023	SELL	$28.28 - $38.36 $98,980 - $134,260	-3,500 Reduced 48.61%	3,700 $118,000
Q2 2023 Aug 14, 2023	BUY	$17.67 - $31.31 $53,010 - $93,930	3,000 Added 71.43%	7,200 $225,000
Q1 2023 May 15, 2023	SELL	$17.13 - $38.52 $1,713 - $3,852	-100 Reduced 2.33%	4,200 $95,000
Q4 2022 Feb 14, 2023	BUY	$29.44 - $37.31 $126,592 - $160,433	4,300 New	4,300 $146,000

124

13.2M

25.5K

3.4K

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $551M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.